Which has higher valuation & earnings, MCK or HQY?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.07 HealthEquity $1.31B 6.71 $215.20M $2.67 39.48

Is MCK or HQY more profitable?

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% HealthEquity 17.25% 14.75% 9.22%

Does the media refer more to MCK or HQY?

In the previous week, McKesson had 61 more articles in the media than HealthEquity. MarketBeat recorded 74 mentions for McKesson and 13 mentions for HealthEquity. McKesson's average media sentiment score of 1.57 beat HealthEquity's score of 1.40 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 68 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive HealthEquity 10 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, MCK or HSIC?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.07 Henry Schein $13.18B 0.75 $398M $3.43 25.80

Is MCK or HSIC more profitable?

Henry Schein has a net margin of 2.96% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 15.97% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Henry Schein 2.96% 15.97% 5.56%

Does the media refer more to MCK or HSIC?

In the previous week, McKesson had 64 more articles in the media than Henry Schein. MarketBeat recorded 74 mentions for McKesson and 10 mentions for Henry Schein. McKesson's average media sentiment score of 1.57 beat Henry Schein's score of 0.93 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 68 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive Henry Schein 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MMSI or MCK?

In the previous week, McKesson had 62 more articles in the media than Merit Medical Systems. MarketBeat recorded 74 mentions for McKesson and 12 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.57 beat Merit Medical Systems' score of 0.99 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 68 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable earnings and valuation, MCK or NEOG?

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.07 Neogen $870.40M 2.99 -$7.90M -$0.03 N/A

Is MCK or NEOG more profitable?

McKesson has a net margin of 1.12% compared to Neogen's net margin of -0.91%. Neogen's return on equity of 2.78% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Neogen -0.91% 2.78% 1.74%

Does the media prefer MCK or NEOG?

In the previous week, McKesson had 72 more articles in the media than Neogen. MarketBeat recorded 74 mentions for McKesson and 2 mentions for Neogen. McKesson's average media sentiment score of 1.57 beat Neogen's score of 0.88 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 68 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive Neogen 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMN or MCK?

In the previous week, McKesson had 67 more articles in the media than AMN Healthcare Services. MarketBeat recorded 74 mentions for McKesson and 7 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.57 beat AMN Healthcare Services' score of 0.82 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 68 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive

McKesson (MCK) Competitors

$862.27 +23.52 (+2.80%)

As of 08/21/2026 03:58 PM Eastern

Compare

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

Should you buy McKesson stock or one of its competitors? McKesson's main competitors and comparable companies include HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), Neogen (NEOG), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

McKesson currently has a consensus price target of $973.44, suggesting a potential upside of 12.89%. HealthEquity has a consensus price target of $110.93, suggesting a potential upside of 5.24%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.07
HealthEquity	$1.31B	6.71	$215.20M	$2.67	39.48

85.1% of McKesson shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
HealthEquity	17.25%	14.75%	9.22%

McKesson has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market.

In the previous week, McKesson had 61 more articles in the media than HealthEquity. MarketBeat recorded 74 mentions for McKesson and 13 mentions for HealthEquity. McKesson's average media sentiment score of 1.57 beat HealthEquity's score of 1.40 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	68 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive
HealthEquity	10 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.07
Henry Schein	$13.18B	0.75	$398M	$3.43	25.80

Henry Schein has a net margin of 2.96% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 15.97% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Henry Schein	2.96%	15.97%	5.56%

In the previous week, McKesson had 64 more articles in the media than Henry Schein. MarketBeat recorded 74 mentions for McKesson and 10 mentions for Henry Schein. McKesson's average media sentiment score of 1.57 beat Henry Schein's score of 0.93 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	68 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Henry Schein	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

85.1% of McKesson shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 12.89%. Henry Schein has a consensus price target of $92.93, indicating a potential upside of 5.01%. Given McKesson's stronger consensus rating and higher probable upside, equities research analysts clearly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

Merit Medical Systems currently has a consensus target price of $100.00, suggesting a potential upside of 10.16%. McKesson has a consensus target price of $973.44, suggesting a potential upside of 12.89%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.67
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

In the previous week, McKesson had 62 more articles in the media than Merit Medical Systems. MarketBeat recorded 74 mentions for McKesson and 12 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.57 beat Merit Medical Systems' score of 0.99 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	68 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.58	$128.49M	$2.42	37.51
McKesson	$403.43B	0.25	$4.76B	$37.37	23.07

Merit Medical Systems has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to McKesson's net margin of 1.12%. Merit Medical Systems' return on equity of 13.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
McKesson	1.12%	-253.21%	5.90%

Summary

Merit Medical Systems and McKesson tied by winning 8 of the 16 factors compared between the two stocks.

How does McKesson compare to Neogen?

McKesson (NYSE:MCK) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

85.1% of McKesson shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 0.6% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

McKesson presently has a consensus price target of $973.44, suggesting a potential upside of 12.89%. Neogen has a consensus price target of $11.67, suggesting a potential downside of 2.37%. Given McKesson's stronger consensus rating and higher possible upside, analysts plainly believe McKesson is more favorable than Neogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Neogen	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

McKesson has a net margin of 1.12% compared to Neogen's net margin of -0.91%. Neogen's return on equity of 2.78% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Neogen	-0.91%	2.78%	1.74%

McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market. Comparatively, Neogen has a beta of 1.77, meaning that its share price is 77% more volatile than the broader market.

In the previous week, McKesson had 72 more articles in the media than Neogen. MarketBeat recorded 74 mentions for McKesson and 2 mentions for Neogen. McKesson's average media sentiment score of 1.57 beat Neogen's score of 0.88 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	68 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Neogen	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.07
Neogen	$870.40M	2.99	-$7.90M	-$0.03	N/A

Summary

McKesson beats Neogen on 11 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

AMN Healthcare Services currently has a consensus target price of $31.43, indicating a potential downside of 8.85%. McKesson has a consensus target price of $973.44, indicating a potential upside of 12.89%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

AMN Healthcare Services has a net margin of 3.06% compared to McKesson's net margin of 1.12%. AMN Healthcare Services' return on equity of 19.92% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
McKesson	1.12%	-253.21%	5.90%

In the previous week, McKesson had 67 more articles in the media than AMN Healthcare Services. MarketBeat recorded 74 mentions for McKesson and 7 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.57 beat AMN Healthcare Services' score of 0.82 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	68 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive

AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market.

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.49	-$95.70M	$2.68	12.87
McKesson	$403.43B	0.25	$4.76B	$37.37	23.07

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

McKesson beats AMN Healthcare Services on 9 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$100.14B	$9.83B	$7.37B	$24.30B
Dividend Yield	0.38%	2.55%	2.53%	3.70%
P/E Ratio	23.07	34.38	272.60	30.31
Price / Sales	0.25	5.00	624.33	19.95
Price / Cash	18.85	125.12	78.62	32.49
Price / Book	-26.02	4.05	13.05	6.77
Net Income	$4.76B	$311.06M	$3.47B	$1.07B
7 Day Performance	-0.74%	0.83%	2.09%	-0.65%
1 Month Performance	4.55%	2.42%	6.64%	3.38%
1 Year Performance	25.38%	15.69%	25.02%	14.90%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.9004 of 5 stars	$862.27 +2.8%	$973.44 +12.9%	+25.4%	$100.14B	$403.43B	23.07	43,000	News Coverage Positive News Analyst Forecast
HQY HealthEquity	4.0016 of 5 stars	$102.33 -2.3%	$110.93 +8.4%	+17.4%	$8.76B	$1.31B	38.33	2,814	News Coverage Positive News Upcoming Earnings Analyst Upgrade
HSIC Henry Schein	3.202 of 5 stars	$89.52 -0.3%	$92.27 +3.1%	+27.2%	$10.00B	$13.18B	26.10	25,000	Analyst Forecast
MMSI Merit Medical Systems	3.4444 of 5 stars	$89.73 -1.1%	$100.00 +11.4%	+1.5%	$5.42B	$1.52B	37.08	7,500	Analyst Upgrade Analyst Revision
NEOG Neogen	2.4038 of 5 stars	$11.87 +1.9%	$11.67 -1.7%	+111.9%	$2.54B	$870.40M	N/A	2,110

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to Neogen?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Do analysts recommend MCK or HQY?

Which has higher valuation & earnings, MCK or HQY?

Do insiders & institutionals hold more shares of MCK or HQY?

Is MCK or HQY more profitable?

Which has more volatility & risk, MCK or HQY?

Does the media refer more to MCK or HQY?

Summary

How does McKesson compare to Henry Schein?

Which has stronger valuation & earnings, MCK or HSIC?

Is MCK or HSIC more profitable?

Does the media refer more to MCK or HSIC?

Which has more volatility and risk, MCK or HSIC?

Do insiders and institutionals have more ownership in MCK or HSIC?

Do analysts recommend MCK or HSIC?

Summary

How does McKesson compare to Merit Medical Systems?

Do analysts rate MMSI or MCK?

Does the media prefer MMSI or MCK?

Do insiders & institutionals believe in MMSI or MCK?

Which has higher valuation and earnings, MMSI or MCK?

Which has more volatility and risk, MMSI or MCK?

Is MMSI or MCK more profitable?

Summary

How does McKesson compare to Neogen?

Do insiders and institutionals hold more shares of MCK or NEOG?

Do analysts prefer MCK or NEOG?

Is MCK or NEOG more profitable?

Which has more volatility and risk, MCK or NEOG?

Does the media prefer MCK or NEOG?

Which has preferable earnings and valuation, MCK or NEOG?

Summary

How does McKesson compare to AMN Healthcare Services?

Do analysts prefer AMN or MCK?

Is AMN or MCK more profitable?

Does the media prefer AMN or MCK?

Which has more risk and volatility, AMN or MCK?

Which has better valuation and earnings, AMN or MCK?

Do insiders and institutionals have more ownership in AMN or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools